Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations

Liu, JH; Zhao, RG; Jiang, XW; Li, ZH; Zhang, B

Zhang, B (通讯作者)，Weifang Med Univ, Sch Pharm, Weifang 261053, Peoples R China.

BIOMOLECULES, 2022; 12 (1):

Abstract

Bortezomib (BTZ) is the first proteasome inhibitor approved by the Food and Drug Administration. It can bind to the amino acid residues of the 26S pro......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索